₹ 122.00
4.55 (3.87%)
BSE
G
Godavari Drugs
₹ 122.00
BSE
GODAVARI Financials Summary
Godavari Drugs revenue remained largely flat at ₹28 Cr in Sep 2026, while net profit decreased 9.09% quarter-on-quarter to ₹1 Cr. Compared to the same quarter last year, revenue is up 2.93% and net profit was largely unchanged. EPS for the quarter stood at ₹0.94, decreased from ₹1.10 in the previous quarter and down from ₹1.33 a year ago.
Godavari Drugs Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of GODAVARI Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
GODAVARI Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






